ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Edwards Lifesciences Corporation Transaction History

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP portfolio value:

$200.86M
portfolio value

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP quarter portfolio value change:

-13.10%
quarter

Edwards Lifesciences Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -13.07% -365.61K shares -65.05M $82.63 2.43M
Q2 2022 share Decrease -15.57% -515.59K shares -123.98M $95.09 2.79M
Q1 2022 share Increase +1.57% 51.14K shares -32.55M $117.72 3.31M
Q4 2021 share Increase +27.78% 708.92K shares 133.54M $130.68 3.26M
Q3 2021 share Increase +72.73% 1.07M shares 135.89M $113.21 2.55M
Q2 2021 share Increase +53.07% 512.26K shares 72.29M $103.57 1.47M
Q1 2021 share Increase +4021.73% 941.85K shares 78.59M $83.64 965.26K
Q4 2020 share Decrease -91.20% -242.66K shares -19.10M $91.23 23.41K
Q3 2020 share Decrease -85.53% -1.57M shares -105.84M $79.82 266.08K
Q2 2020 share Decrease -25.60% -632.67K shares -28.31M $69.11 1.83M
Q1 2020 share Increase +50.96% 834.34K shares 28.08M $62.87 2.47M
Q4 2019 share Increase 0.00% 1.63M shares 127.31M $77.76 1.63M
Q3 2019 share Decrease -100.00% -70.77K shares -4.35M $73.3 0
Q2 2019 share Decrease -80.17% -286.16K shares -18.40M $61.58 70.77K
Q1 2019 share Increase +352.31% 278.02K shares 18.73M $63.78 356.94K
Q4 2018 share Decrease -94.72% -1.41M shares -82.69M $51.06 78.91K
Q3 2018 share Increase +15.43% 199.76K shares 23.90M $58.03 1.49M
Q2 2018 share Increase +33.09% 321.86K shares 17.57M $48.52 1.29M
Q1 2018 share Increase +184.09% 630.31K shares 32.37M $46.51 972.71K
Q4 2017 share Decrease -80.39% -1.40M shares -50.75M $37.57 342.39K
Q3 2017 share Decrease -28.44% -694.04K shares -32.55M $36.44 1.74M
Q2 2017 share Increase +18.88% 387.51K shares 31.81M $39.41 2.44M
Q1 2017 share Increase 0.00% 2.05M shares 64.36M $31.36 2.05M